These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 34313009)
1. An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma. Chen D; Wang M; Guo Y; Wu W; Ji X; Dou X; Tang H; Zong Z; Zhang X; Xiong D Cancer Med; 2021 Sep; 10(17):5936-5947. PubMed ID: 34313009 [TBL] [Abstract][Full Text] [Related]
2. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma. Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463 [TBL] [Abstract][Full Text] [Related]
3. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related]
4. Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma. Pan Y; Song Y; Cheng L; Xu H; Liu J J Cell Biochem; 2019 Dec; 120(12):19482-19495. PubMed ID: 31264288 [TBL] [Abstract][Full Text] [Related]
5. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma. Ye MH; Huang XY; Li CJ; Wu QJ; Liu F Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma. Ma J; Li R; Wang J Mol Med Rep; 2019 Jul; 20(1):622-632. PubMed ID: 31180552 [TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer. Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma. Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094 [TBL] [Abstract][Full Text] [Related]
9. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma. Yang F; Zhou LQ; Yang HW; Wang YJ Front Genet; 2022; 13():927614. PubMed ID: 36092911 [No Abstract] [Full Text] [Related]
10. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma. Wang YL; Zhang YY Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555 [TBL] [Abstract][Full Text] [Related]
11. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma. Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
13. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma. Zhao X; Cui L J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation biomarkers for head and neck squamous cell carcinoma. Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694 [TBL] [Abstract][Full Text] [Related]
15. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
16. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance. Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H Front Immunol; 2022; 13():961695. PubMed ID: 36389709 [TBL] [Abstract][Full Text] [Related]
17. Risk model-guided identification of MTDH expression as a marker for ferroptosis induction therapy in head and neck squamous cell carcinoma. Wang X; Gao Y; Miao R; Li L; Nanding A; Liu Y; Zhang X Am J Cancer Res; 2023; 13(11):5236-5253. PubMed ID: 38058815 [TBL] [Abstract][Full Text] [Related]
18. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma. Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663 [TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma. Liu J; Lu J; Li W BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]